NM_001852.4:c.1003C>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001852.4(COL9A2):​c.1003C>G​(p.Leu335Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.119 in 1,613,598 control chromosomes in the GnomAD database, including 12,060 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L335I) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.098 ( 766 hom., cov: 32)
Exomes 𝑓: 0.12 ( 11294 hom. )

Consequence

COL9A2
NM_001852.4 missense

Scores

3
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.394

Publications

28 publications found
Variant links:
Genes affected
COL9A2 (HGNC:2218): (collagen type IX alpha 2 chain) This gene encodes one of the three alpha chains of type IX collagen, the major collagen component of hyaline cartilage. Type IX collagen, a heterotrimeric molecule, is usually found in tissues containing type II collagen, a fibrillar collagen. This chain is unusual in that, unlike the other two type IX alpha chains, it contains a covalently attached glycosaminoglycan side chain. Mutations in this gene are associated with multiple epiphyseal dysplasia. [provided by RefSeq, Jul 2008]
COL9A2 Gene-Disease associations (from GenCC):
  • epiphyseal dysplasia, multiple, 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • Stickler syndrome, type 5
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
  • multiple epiphyseal dysplasia due to collagen 9 anomaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive Stickler syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Stickler syndrome
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0024698377).
BP6
Variant 1-40307451-G-C is Benign according to our data. Variant chr1-40307451-G-C is described in ClinVar as Benign. ClinVar VariationId is 258364.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.119 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL9A2NM_001852.4 linkc.1003C>G p.Leu335Val missense_variant Exon 19 of 32 ENST00000372748.8 NP_001843.1 Q14055

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL9A2ENST00000372748.8 linkc.1003C>G p.Leu335Val missense_variant Exon 19 of 32 1 NM_001852.4 ENSP00000361834.3 Q14055
COL9A2ENST00000482722.5 linkn.1306C>G non_coding_transcript_exon_variant Exon 18 of 31 1

Frequencies

GnomAD3 genomes
AF:
0.0984
AC:
14978
AN:
152186
Hom.:
768
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0667
Gnomad AMI
AF:
0.115
Gnomad AMR
AF:
0.0985
Gnomad ASJ
AF:
0.0541
Gnomad EAS
AF:
0.0993
Gnomad SAS
AF:
0.112
Gnomad FIN
AF:
0.0843
Gnomad MID
AF:
0.101
Gnomad NFE
AF:
0.121
Gnomad OTH
AF:
0.0979
GnomAD2 exomes
AF:
0.104
AC:
26061
AN:
250194
AF XY:
0.106
show subpopulations
Gnomad AFR exome
AF:
0.0651
Gnomad AMR exome
AF:
0.0812
Gnomad ASJ exome
AF:
0.0641
Gnomad EAS exome
AF:
0.124
Gnomad FIN exome
AF:
0.0842
Gnomad NFE exome
AF:
0.120
Gnomad OTH exome
AF:
0.102
GnomAD4 exome
AF:
0.121
AC:
177507
AN:
1461294
Hom.:
11294
Cov.:
32
AF XY:
0.120
AC XY:
87578
AN XY:
726898
show subpopulations
African (AFR)
AF:
0.0617
AC:
2067
AN:
33478
American (AMR)
AF:
0.0841
AC:
3757
AN:
44654
Ashkenazi Jewish (ASJ)
AF:
0.0627
AC:
1638
AN:
26128
East Asian (EAS)
AF:
0.0876
AC:
3477
AN:
39692
South Asian (SAS)
AF:
0.112
AC:
9645
AN:
86186
European-Finnish (FIN)
AF:
0.0849
AC:
4531
AN:
53386
Middle Eastern (MID)
AF:
0.0640
AC:
369
AN:
5768
European-Non Finnish (NFE)
AF:
0.131
AC:
145221
AN:
1111660
Other (OTH)
AF:
0.113
AC:
6802
AN:
60342
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
8220
16441
24661
32882
41102
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5360
10720
16080
21440
26800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0984
AC:
14982
AN:
152304
Hom.:
766
Cov.:
32
AF XY:
0.0956
AC XY:
7124
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.0665
AC:
2764
AN:
41562
American (AMR)
AF:
0.0987
AC:
1511
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0541
AC:
188
AN:
3472
East Asian (EAS)
AF:
0.0991
AC:
514
AN:
5186
South Asian (SAS)
AF:
0.111
AC:
538
AN:
4832
European-Finnish (FIN)
AF:
0.0843
AC:
895
AN:
10612
Middle Eastern (MID)
AF:
0.0918
AC:
27
AN:
294
European-Non Finnish (NFE)
AF:
0.121
AC:
8227
AN:
68014
Other (OTH)
AF:
0.101
AC:
213
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
732
1464
2197
2929
3661
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
168
336
504
672
840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.108
Hom.:
775
Bravo
AF:
0.0974
TwinsUK
AF:
0.139
AC:
515
ALSPAC
AF:
0.139
AC:
536
ESP6500AA
AF:
0.0738
AC:
325
ESP6500EA
AF:
0.113
AC:
974
ExAC
AF:
0.104
AC:
12622
Asia WGS
AF:
0.0980
AC:
342
AN:
3478
EpiCase
AF:
0.115
EpiControl
AF:
0.113

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 06, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Epiphyseal dysplasia, multiple, 2 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.086
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.27
CADD
Benign
17
DANN
Uncertain
0.99
DEOGEN2
Benign
0.17
T
Eigen
Benign
-0.079
Eigen_PC
Benign
-0.054
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Uncertain
0.94
D
MetaRNN
Benign
0.0025
T
MetaSVM
Benign
-0.63
T
MutationAssessor
Benign
1.4
L
PhyloP100
0.39
PrimateAI
Benign
0.45
T
PROVEAN
Benign
-0.84
N
REVEL
Benign
0.24
Sift
Benign
0.050
D
Sift4G
Benign
0.093
T
Polyphen
0.82
P
Vest4
0.12
MPC
0.68
ClinPred
0.015
T
GERP RS
3.0
Varity_R
0.13
gMVP
0.17
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2228567; hg19: chr1-40773123; COSMIC: COSV65607113; COSMIC: COSV65607113; API